|
|
 Previous Article | Table of Contents | Next Article 
Blood, 15 September 2000, Vol. 96, No. 6, pp. 2134-2139
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
ADP induces partial platelet aggregation without shape change and
potentiates collagen-induced aggregation in the absence of
G q
Philippe Ohlmann,
Anita Eckly,
Monique Freund,
Jean-Pierre Cazenave,
Stefan Offermanns, and
Christian Gachet
From INSERM U.311, Etablissement Français
du Sang-Alsace, Strasbourg, France, and Institut für
Pharmakologie, Freie Universität Berlin, Berlin, Germany.
Platelets from G q knockout mice are unable to aggregate in
response to physiological agonists like adenosine
5'-diphosphate (ADP), thromboxane A2, thrombin, or
collagen, although shape change still occurs in response to all of
these agonists except ADP. ADP-induced platelet aggregation results
from simultaneous activation of the purinergic P2Y1
receptor coupled to calcium mobilization and shape change and of a
distinct P2 receptor, P2cyc, coupled through Gi to adenylyl cyclase
inhibition, which is responsible for completion and amplification of
the response. P2cyc could be the molecular target of the antithrombotic
drug clopidogrel and the adenosine triphosphate (ATP) analogs
AR-C69931MX, AR-C67085, and AR-C66096. The aim of the
present study was to determine whether externally added ADP could still
act through the Gi pathway in Gq-deficient mouse platelets and
thereby amplify the residual responses to agonists such as thrombin or
collagen. It was found that (1) ADP and adrenaline still inhibited
cyclic AMP accumulation in Gq-deficient platelets; (2) both agonists
restored collagen- but not thrombin-induced aggregation in
these platelets; (3) the effects of ADP were selectively inhibited in
vitro by the ATP analog AR-C69931MX and ex vivo by clopidogrel and
hence were apparently mediated by the P2cyc receptor; and (4) high
concentrations of ADP (100 µmol/L) induced aggregation without shape
change in Gq-deficient platelets through activation of P2cyc. Since
adrenaline was not able to induce platelet aggregation even at high
concentrations, we conclude that the effects of ADP mediated by P2cyc
are not restricted to the inhibition of adenylyl cyclase
through Gi2.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
S. Kim, A. Garcia, S. P. Jackson, and S. P. Kunapuli
Insulin-like growth factor-1 regulates platelet activation through PI3-K{alpha} isoform
Blood,
December 15, 2007;
110(13):
4206 - 4213.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Schoenwaelder, A. Ono, S. Sturgeon, S. M. Chan, P. Mangin, M. J. Maxwell, S. Turnbull, M. Mulchandani, K. Anderson, G. Kauffenstein, et al.
Identification of a Unique Co-operative Phosphoinositide 3-Kinase Signaling Mechanism Regulating Integrin {alpha}IIbbeta3 Adhesive Function in Platelets
J. Biol. Chem.,
September 28, 2007;
282(39):
28648 - 28658.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Tolhurst, C. Vial, C. Leon, C. Gachet, R. J. Evans, and M. P. Mahaut-Smith
Interplay between P2Y1, P2Y12, and P2X1 receptors in the activation of megakaryocyte cation influx currents by ADP: evidence that the primary megakaryocyte represents a fully functional model of platelet P2 receptor signaling
Blood,
September 1, 2005;
106(5):
1644 - 1651.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Murugappan, H. Shankar, S. Bhamidipati, R. T. Dorsam, J. Jin, and S. P. Kunapuli
Molecular mechanism and functional implications of thrombin-mediated tyrosine phosphorylation of PKC{delta} in platelets
Blood,
July 15, 2005;
106(2):
550 - 557.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Hechler, S. Magnenat, M. L. Zighetti, M. U. Kassack, H. Ullmann, J.-P. Cazenave, R. Evans, M. Cattaneo, and C. Gachet
Inhibition of Platelet Functions and Thrombosis through Selective or Nonselective Inhibition of the Platelet P2 Receptors with Increasing Doses of NF449 [4,4',4'',4'''-(Carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic Acid Octasodium Salt]
J. Pharmacol. Exp. Ther.,
July 1, 2005;
314(1):
232 - 243.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Nonne, N. Lenain, B. Hechler, P. Mangin, J.-P. Cazenave, C. Gachet, and F. Lanza
Importance of Platelet Phospholipase C{gamma}2 Signaling in Arterial Thrombosis as a Function of Lesion Severity
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2005;
25(6):
1293 - 1298.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. R. Hardy, M. L. Jones, S. J. Mundell, and A. W. Poole
Reciprocal cross-talk between P2Y1 and P2Y12 receptors at the level of calcium signaling in human platelets
Blood,
September 15, 2004;
104(6):
1745 - 1752.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Haseruck, W. Erl, D. Pandey, G. Tigyi, P. Ohlmann, C. Ravanat, C. Gachet, and W. Siess
The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors
Blood,
April 1, 2004;
103(7):
2585 - 2592.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Mangin, Y. Yuan, I. Goncalves, A. Eckly, M. Freund, J.-P. Cazenave, C. Gachet, S. P. Jackson, and F. Lanza
Signaling Role for Phospholipase C{gamma}2 in Platelet Glycoprotein Ib{alpha} Calcium Flux and Cytoskeletal Reorganization: INVOLVEMENT OF A PATHWAY DISTINCT FROM FcR{gamma} CHAIN AND Fc{gamma}RIIA
J. Biol. Chem.,
August 29, 2003;
278(35):
32880 - 32891.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Hechler, N. Lenain, P. Marchese, C. Vial, V. Heim, M. Freund, J.-P. Cazenave, M. Cattaneo, Z. M. Ruggeri, R. Evans, et al.
A Role of the Fast ATP-gated P2X1 Cation Channel in Thrombosis of Small Arteries In Vivo
J. Exp. Med.,
August 18, 2003;
198(4):
661 - 667.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. M. Patel, K. Patel, S. Rahman, M. P. Smith, G. Spooner, R. Sumathipala, M. Mitchell, G. Flynn, A. Aitken, and G. Savidge
Evidence for a role for G{alpha}i1 in mediating weak agonist-induced platelet aggregation in human platelets: reduced G{alpha}i1 expression and defective Gi signaling in the platelets of a patient with a chronic bleeding disorder
Blood,
June 15, 2003;
101(12):
4828 - 4835.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Nieswandt, V. Schulte, A. Zywietz, M.-P. Gratacap, and S. Offermanns
Costimulation of Gi- and G12/G13-mediated Signaling Pathways Induces Integrin alpha IIbbeta 3 Activation in Platelets
J. Biol. Chem.,
October 11, 2002;
277(42):
39493 - 39498.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. M. Quinton, F. Ozdener, C. Dangelmaier, J. L. Daniel, and S. P. Kunapuli
Glycoprotein VI-mediated platelet fibrinogen receptor activation occurs through calcium-sensitive and PKC-sensitive pathways without a requirement for secreted ADP
Blood,
May 1, 2002;
99(9):
3228 - 3234.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Lova, S. Paganini, F. Sinigaglia, C. Balduini, and M. Torti
A Gi-dependent Pathway Is Required for Activation of the Small GTPase Rap1B in Human Platelets
J. Biol. Chem.,
March 29, 2002;
277(14):
12009 - 12015.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. J. Greco, G. Tonon, W. Chen, X. Luo, R. Dalal, and G. A. Jamieson
Novel structurally altered P2X1 receptor is preferentially activated by adenosine diphosphate in platelets and megakaryocytic cells
Blood,
July 1, 2001;
98(1):
100 - 107.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Nieswandt, W. Bergmeier, A. Eckly, V. Schulte, P. Ohlmann, J.-P. Cazenave, H. Zirngibl, S. Offermanns, and C. Gachet
Evidence for cross-talk between glycoprotein VI and Gi-coupled receptors during collagen-induced platelet aggregation
Blood,
June 15, 2001;
97(12):
3829 - 3835.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Bergmeier, D. Bouvard, J. A. Eble, R. Mokhtari-Nejad, V. Schulte, H. Zirngibl, C. Brakebusch, R. Fassler, and B. Nieswandt
Rhodocytin (Aggretin) Activates Platelets Lacking alpha 2beta 1 Integrin, Glycoprotein VI, and the Ligand-binding Domain of Glycoprotein Ibalpha
J. Biol. Chem.,
June 29, 2001;
276(27):
25121 - 25126.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
